Poor clinical outcome of relapsed/refractory diffuse large B-cell lymphoma with MYC translocation treated with polatuzumab vedotin, bendamustine, and rituximab

J Clin Exp Hematop. 2023 Jul 28. doi: 10.3960/jslrt.23017. Online ahead of print.NO ABSTRACTPMID:37518271 | DOI:10.3960/jslrt.23017

Source: Journal of Clinical and Experimental Hematopathology : JCEH - July 30, 2023 Category: Hematology Authors: Masuho Saburi Masanori Sakata Yousuke Kodama Keiichi Uraisami Hiroyuki Takata Yasuhiko Miyazaki Junpei Wada Shogo Urabe Eiichi Ohtsuka Source Type: research